lupus

GSK to pay $300M to license drug it sees as potential lupus treatment
BioPharma Dive
Tue, 10/29/24 - 11:38 am
GSK
China
Chimagen
lupus
T-cell engager
Kezar Life Sciences pauses trial for lupus treatment after patient deaths
Reuters
Mon, 09/30/24 - 08:34 pm
Kezar Life Sciences
lupus
clinical trials
patient deaths
Kezar stalls solid tumor trial to focus on autoimmune disease candidate
Pharmaceutical Technology
Wed, 08/14/24 - 11:05 am
Kezar Life Sciences
zetomipzomib
clinical trials
lupus
autoimmune hepatitis
solid tumors
Viatris splashes out $350m on pair of Idorsia therapies
Pharmaphorum
Wed, 02/28/24 - 10:45 am
Viatris
Idorsia
lupus
myocardial infarction
selatogrel
cenerimod
Galapagos halts lupus CAR-T program, confirms 100 layoffs so far this year
Fierce Biotech
Fri, 02/23/24 - 10:32 am
Galapagos
layoffs
lupus
CAR-T
Roivant ends longshot lupus program after phase 2 fail
Fierce Biotech
Tue, 11/28/23 - 10:32 am
Roivant
lupus
clinical trials
brepocitnib
AbbVie and Lupus Therapeutics partner for SLE trial recruitment
Clinical Trials Arena
Wed, 10/25/23 - 09:40 am
AbbVie
Lupus Therapeutics
systemic lupus erythematosus
lupus
Rinvoq
clinical trials
Gilead-backed cell therapy startup Kyverna adds fresh funds for new strategy
BioPharma Dive
Thu, 08/3/23 - 10:12 am
Kyverna Therapeutics
lupus
Gilead Sciences
Treg cell therapy
Amgen’s lupus bets continue to flounder, even those on the Horizon
Fierce Biotech
Mon, 07/24/23 - 10:24 am
Horizon Therapeutics
Amgen
lupus
daxdilimab
clinical trials
GSK underscores organ damage risks for lupus patients in It Will campaign
Medical Marketing and Media
Fri, 07/14/23 - 10:19 am
GSK
DTC ads
lupus
AbbVie's Rinvoq passes midstage test in systemic lupus erythematosus, heads into phase 3
Fierce Pharma
Wed, 05/31/23 - 11:06 am
AbbVie
Rinvoq
Humira
systemic lupus erythematosus
lupus
clinical trials
Amgen cuts lupus programs for futility, hours after Lilly officially walks away from one too
Fierce Biotech
Fri, 04/28/23 - 10:46 am
Amgen
earnings
Eli Lilly
lupus
After gathering enough Nektar, Lilly hands back rights to immunology med post-lupus fail
Fierce Biotech
Thu, 04/27/23 - 11:48 am
Eli Lilly
Nektar Therapeutics
Rezpeg
lupus
Fresh layoffs at Nektar Therapeutics as it drops lupus program after phase 2 disappointment
Biopharma Reporter
Thu, 04/20/23 - 10:47 am
Nektar Therapeutics
lupus
rezpegaldesleukin
layoffs
Rezpeg
New lupus partnership with FDA aims to end drug trials’ history of failure
Stat
Thu, 03/30/23 - 11:08 pm
lupus
FDA
clinical trials
AbbVie clinches back-to-back clinical wins in ulcerative colitis, lupus
BioSpace
Fri, 03/24/23 - 11:50 am
AbbVie
Skyrizi
ulcerative colitis
lupus
Rinvoq
clinical trials
Nektar's bitter pill: Phase 2 fail ends Lilly-partnered lupus program and prompts eczema rethink
Fierce Biotech
Fri, 02/24/23 - 09:27 am
Nektar Therapeutics
rezpegaldesleukin
clinical trials
lupus
Gilead, EVOQ Unite on 'Potential Breakthrough' Treatment for RA, Lupus
BioSpace
Tue, 01/3/23 - 10:28 pm
Gilead Sciences
Evoq Therapeutics
lupus
rheumatoid arthritis
GSK survey finds COVID, lack of early HCP conversations hitting lupus patients' care
Fierce Pharma
Tue, 11/29/22 - 08:29 pm
GSK
lupus
Benlysta
patients
COVID-19
pharma marketing
Biogen’s Antibody Lupus Treatment Shows Mid-Stage Promise
BioSpace
Fri, 09/9/22 - 11:07 am
Biogen
litifilimab
lupus
systemic lupus erythematosus
monoclonal antibodies
clinical trials

Pages